TERT-BUTYL 4-((6-(2-(QUINOXALINE-2-CARBOXAMIDO)PHENYL)IMIDAZO[2,1-B]THIAZOL-3-YL)METHYL)PIPERAZINE-1-CARBOXYLATE structure
|
Common Name | TERT-BUTYL 4-((6-(2-(QUINOXALINE-2-CARBOXAMIDO)PHENYL)IMIDAZO[2,1-B]THIAZOL-3-YL)METHYL)PIPERAZINE-1-CARBOXYLATE | ||
---|---|---|---|---|
CAS Number | 925436-46-0 | Molecular Weight | 569.67700 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C30H31N7O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | tert-butyl 4-[[6-[2-(quinoxaline-2-carbonylamino)phenyl]imidazo[2,1-b][1,3]thiazol-3-yl]methyl]piperazine-1-carboxylate |
---|
Molecular Formula | C30H31N7O3S |
---|---|
Molecular Weight | 569.67700 |
Exact Mass | 569.22100 |
PSA | 133.20000 |
LogP | 5.25980 |
HS Code | 2934100090 |
---|
~% TERT-BUTYL 4-((... CAS#:925436-46-0 |
Literature: Sirtris Pharmaceuticals, Inc. Patent: US2008/249103 A1, 2008 ; Location in patent: Page/Page column 35 ; US 20080249103 A1 |
Precursor 1 | |
---|---|
DownStream 1 | |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |